Stockreport

AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate [Yahoo! Finance]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF treatment of inflammatory bowel disease (IBD), from the Chinese biotech FutureGen Biopharmaceutical. IBD includes two conditions, Crohn's disease (CD) and ulcerative c [Read more]